Xechem International to set up anti-cancer drugs facility at SiruseriIllustrative image – not actual.

Xechem International Inc, a New Jersey-based company, has plans to set up a 100 per cent export-oriented facility to manufacture anti-cancer compounds and drugs using medicinal plants and trees at Siruseri in Tamil Nadu. The plant would produce 60 kg of paclitaxel annually, half of which used to make nine anti-cancer formulations.

 

The facility would come up on 40 acres of land at the Biotech Park for which the State Industries Promotion Corporation of Tamil Nadu has acquired land.

 

The project would be set up in phases. The first phase would entail an investment of Rs.100 crore, while the second phase the company would involve an investment of Rs.50 crore for setting up a R & D centre. The machinery and the equipment, most of which would be imported, would cost about Rs.30 crore.

 

A new company - Xechem Pharmaceuticals India, would be set up, in which Xechem International is likely to hold up to 80 per cent equity. The project would have a debt equity ratio of 1:1. The Tamil Nadu Industrial Development Corporation is also likely to take up stake in the project. The plant would commence operations within 20 months from October 2002.

← All latest storiesBack to top →